|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.3 SEK | +15.56% |
|
-1.89% | -67.58% |
| Mar. 13 | OmneDiem Launches Two New Products | CI |
| Mar. 05 | AXichem AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
aXichem AB reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was SEK 5.01 million compared to SEK 4.36 million a year ago. Revenue was SEK 5.22 million compared to SEK 4.44 million a year ago.
Net loss was SEK 17.26 million compared to SEK 15.09 million a year ago. Basic loss per share from continuing operations was SEK 1.04 compared to SEK 0.92 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -67.58% | 4.19M | |
| +0.58% | 4.41B | |
| +11.90% | 1.74B | |
| -15.01% | 630M | |
| -3.50% | 540M | |
| -81.65% | 216M | |
| -14.25% | 110M | |
| -11.41% | 52.86M |
AXICHEM AB 